Cosmetic Surgery and Procedures Market Projected to Grow at a Steady Pace

Stratview Research has published a new report on the Cosmetic Surgery and Procedures Market, segmented By Type (Surgical (Breast Surgery, Body and Extremities, Face Surgery), Nonsurgical (Injectables, Facial Rejuvenation, Others)), End-User (Hospitals, Office-based Facilities, Ambulatory Surgical Centers), and Region.

This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global artificial intelligence as a service market.

Market Highlights

The Cosmetic Surgery and Procedures market is projected to grow from USD 64.16 billion in 2021 to USD 120.21 billion by 2028 at a CAGR of around 9.28% during the forecast period of 2022-2028.

Covid Impact

Covid-19 has impacted the market dynamics, competition, and global supply chain of every possible market one can think of. The revenues for many, have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operations and strategy will sustain and beat the competition.

Segmentation –

This report studies the Cosmetic Surgery and Procedures Market and has segmented the market in a few ways, keeping in mind the concentration of all the stakeholders across the value chain. Following are the ways in which the market has been segmented in the report:

By end-user, the cosmetic surgery and procedures market has been bifurcated into hospitals, office-based facilities, and ambulatory surgical centers. Under these, the hospitals' segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period.

By region, the market in North America accounted for the largest market share in 2020 and is projected to grow at a significant CAGR during the assessment period. The regional growth is primarily attributed to expanding geriatric populace and rising incidences of skin disorders coupled with the presence of key market players such as Genesis Biosystems (US) and A.P. Pharma, Inc. (US). The market growth in the Asia-Pacific region is expected to be driven by increased spending on cosmetic surgeries and rising medical tourism.

Following are the key players in the Cosmetic Surgery and Procedures Market:

• Sanofi S.A. (France)
• Bausch Health Companies Inc. (Canada)
• Lumenis (Israel)
• Genesis Biosystems (US)
• Covidien (Ireland)
• A.P. Pharma, Inc. (US)
• Zeltiq Aesthetics (US)
• Cynosure (US)
• Allergan, Inc. (Ireland)
• Merz Pharma GmbH & Co. KGaA (Germany)
• Cutera, Inc. (US)
• Ipsen (France)
• Sientra (US)
• ALMA LASERS LTD. (Israel)
• Johnson & Johnson (US).

To know more about the covid impact on the market, click here: https://www.stratviewresearch.com/Request-Sample/2411/Cosmetic-Surgery-and-Procedures-Market.html#form

About Stratview Research-

Stratview Research is a global market intelligence firm having a strong team of industry veterans and research analysts. Stratview Research has been serving multiple clients across a wide array of industries. Our services cover a broad spectrum of industries including but not limited to Energy Chemicals, Advanced Materials, Automotive, and Aerospace. At Stratview, we believe in building long term relations with our clients.

Connect with our team here–
https://www.stratviewresearch.com/contact

Or

Call us @:  +1-313-307-4176

Article source: https://article-realm.com/article/Business/49607-Cosmetic-Surgery-and-Procedures-Market-Projected-to-Grow-at-a-Steady-Pace.html